ACADIA PHARMACEUTICALS INC — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2016-03-15

Reporting Person: Moore Terrence O (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-15	Stock Option (right to buy)	$19.65	A	150000	Acquired	2026-03-14	Common Stock (150000)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable on March 15, 2017. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.